baber/WOPTO huggingface dataset:
Patent PT-1817986-E (PT)
Title: Mattress
Inventor: RAMETSTEINER KARL
IPC: A01N25/34
Filed: 2007-01-23
Abstract: The mattress has biocides equipment on the basis of a silver-bearing zeolite. The polyurethane fiber foam contains 0.1 to 5 weight percent of a silver-bearing zeolite and 0.1 to 2 weight percent of a tertiary amine. The tertiary amine forms an aliphatic, cyclo aliphatic or bicylic compound. The polyurethane fiber foam as tertiary amine contains Dimethylcyclohexylamine through ether, Diazabicyclooctane or N.N-Tetramethylbutandiamine. An independent claim is also included for a method for production of a mattress comprises a conversion of polyol component with an isocyanate component under effect of a blowing agent in a polyaddition to a polyurethane fiber foam.
Patent PT-2043766-E (PT)
Title: Capillary membrane filtration module
Inventor: DOYEN WIM
IPC: B01D63/02
Filed: 2007-07-13
Abstract: The present invention is related to a filtration device for removing particles from a liquid and its method of production, said filtration device comprising: 
¢ A collector header arranged to collect and remove permeate, 
¢ A plurality of planar membrane assemblies having an upper side and a lower side, said lower side being operatively linked to said collector header, 
¢ Said planar membrane assemblies each comprising a plurality of outside-in micro- or ultrafiltration capillary membranes, each capillary membrane extending from said lower side to said upper side of said planar membrane assembly, said plurality of capillary membranes forming a plane, 
¢ Wherein the capillary membranes of each planar membrane assembly are operatively linked to an individual upper header, and wherein the upper headers of each planar membrane assembly and the disposition of the planar membrane assemblies at the lower side are arranged to allow a flow of air bubbles, crude water and particles to pass from said lower side to said upper side and to reduce particle build-up at said upper side.
Patent PT-2231887-E (PT)
Title: Improved modifying flux for molten aluminium
Inventor: MICHARD LAURENT
IPC: C22C1/02
Filed: 2008-12-22
Abstract: Composition for releasing sodium or strontium or both into molten aluminum or aluminum-based alloy. The composition is formed by fusing a mixture containing at least two salts, at least one of the salts having sodium as a cation and/or at least one of the salts having strontium as a cation, at least one of the salts having carbonate as an anion and at least one of the salts having a halide as an anion. The composition may be employed as a modifying flux for altering the microstructure of aluminum and aluminum alloy.
Patent PT-2528978-E (PT)
Title: Coating composition containing composite particles
Inventor: JAHNS EKKEHARD
IPC: C09D133/00
Filed: 2011-01-24
Abstract: The present invention relates to a coating material in the form of an aqueous composition comprising: 25% to 55% by weight of composite particles having an average particle size of 50 to 350 nm, in the form of an aqueous dispersion, which are constructed of 20% to 60% by weight, based on the composite particle, of inorganic solid having an average particle size of 5 to 100 nm, 40% to 80% by weight, based on the composite particle, of a polymer matrix having a T9 in the range from −60 to +40° C. and obtainable by free-radical emulsion polymerization of at least one ethylenically unsaturated monomer, and 20% to 50% by weight of fillers, with 5% to 40% by weight, based on the total solids content, being selected from aluminum silicates, borosilicate glasses, polymethyl methacrylate particles, and polystyrene particles, 1% to 30% by weight of pigments, and 0% to 5% by weight of one or more thickeners 0.1% to 20% by weight of other auxiliaries based in each case on the total solids content, and also to the use thereof for coating surfaces, objects and substrates in permanent water contact, more particularly with swimming pool water.
Patent PT-2637874-E (PT)
Title: Use of composition for improving inkjet printing properties and an inkjet recording sheet
Inventor: SAMI PUTTONEN
IPC: D21H19/64
Filed: 2011-11-08
Abstract: The invention relates to a use of a composition comprising polyaluminium compound and starch solution for improving inkjet printing properties of a ink jet recording sheet by coating or applying it onto the inkjet recording sheet, the inkjet recording sheet comprising wood or lignocellulosic fibre material. The invention relates also to an ink jet recording sheet.
Patent PT-640081-E (PT)
Inventor: OXFORD ALEXANDER WILLIAM
IPC: C07D417/12
Filed: 1993-03-26
Abstract: The present invention relates to substituted carbamates and ureas of formula (V) <CHEM> wherein R<1> represents a hydrogen or a halogen atom, or a C1-6alkyl, C1-6alkoxy or hydroxy group;   R<2> represents an oxadiazole or thiadiazole ring substituted by a group selected from C1-6alkyl, C3-7cycloalkyl, -CH2C2-5alkenyl, -CH2C2-5alkynyl, phenyl or benzyl;   X represents NH or an oxygen atom;   and m represents zero, 1 or 2; which compounds are intermediates in the preparation of certain therapeutically active substituted phenylcarbamates and ureas.
Patent PT-646623-E (PT)
Inventor: PRINCIOTTA GUALTIERO
IPC: C08L23/04
Filed: 1994-10-01
Abstract: Suitably flame-retarded compounds based on very low density polyethylenes result to be suitable for applications in which good flexibility, good mechanical properties and excellent fire behaviour are required.
Patent PT-804482-E (PT)
Inventor: BECKMANN M PATRICIA
IPC: C12N5/10
Filed: 1994-08-17
Abstract: Hek ligand (hek-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing hek-L polypeptides. The hek-L polypeptides bind to a cell surface receptor (hek) that is a member of the receptor tyrosine kinase family. Hek is expressed on cells that include certain tumor cell lines. The hek-L polypeptides also bind a distinct receptor tyrosine kinase known elk.
Patent PT-741570-E (PT)
Inventor: KLIMSTRA PAUL DALE
IPC: A61P31/04
Filed: 1995-01-12
Abstract: The present invention provides an article of manufacture comprising: (1) a packaging material, and (2) a once-a-day dose medication which causes a photosensitivity and/or a phototoxicity reaction in a patient contained within said packaging material and wherein said packaging material comprises a label which indicated that such a reaction is prevented or reduced by administering the medication to the patient during the evening or early morning hours.
Patent PT-758919-E (PT)
Inventor: SHUKIS PETER JOSEPH
IPC: B01J23/38
Filed: 1995-05-01
Abstract: Provided is a process for improving the activity of catalysts based upon gamma alumina containing substrates impregnated with one or more catalytically active metals.
Patent PT-808287-E (PT)
Inventor: DEMAREST SCOTT W
IPC: B65D83/14
Filed: 1996-02-13
Abstract: An overcap sprayer assembly and method of its manufacture. The overcap sprayer assembly includes an actuator and an overcap. The actuator has a body and a sprayer arm. The body attaches preferably to the valve cup rim of the can. A skirt extends circumferentially around the perimeter of the body. At least one actuator access port provides access through the skirt to the interior of the body. The sprayer arm of the actuator has a nozzle adapted to direct spray outwardly through an actuator access port. The overcap attaches to the skirt of the actuator body in coaxially turning relation thereto. An overcap wall extends downwardly from the outer margins of the overcap dome, surrounding the actuator body. The overcap also has at least one overcap access port that may be moved between an open position, wherein an overcap access port is aligned with the actuator access port through which the nozzle is adapted to direct spray, and a closed position, wherein the overcap wall obstructs the actuator access port. Preferably a lock member extends from one of the actuator body and the overcap to project into and engage an opposed locking port of the other of the actuator body and overcap. Preferably the locking port is an access port. The lock member has an unlocked position, wherein it is not engaged in an opposed locking port and the overcap may freely turn on the actuator body, and a locked position assumed when the lock member becomes aligned with an opposed locking port, projects thereinto, and engages the opposed locking port, resisting further overcap turning.
Patent PT-795612-E (PT)
Inventor: BACKUS JOHN WESLEY
IPC: C12Q1/68
Filed: 1997-03-11
Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid. The method comprising contacting a sample suspected of containing the target nucleic acid with a thermostable DNA polymerase and two primers that are substantially complementary to the target nucleic acid, under conditions such that the target nucleic acid is amplified. The amplified target nucleic acids are then denatured to form single stranded nucleic acids. Following amplification, the sample is subject to a pre-detection incubation step. The sample is incubated for between 1 second and 30 minutes at between 95 DEG C and 120 DEG C to inactivate said polymerization agent. Finally, the presence or absence of the amplified target nucleic acids is determined.
Patent PT-786434-E (PT)
Inventor: BERTELEAU GERARD
IPC: C06B23/00
Filed: 1997-01-23
Abstract: Ammonium nitrate (AN) stabilised by potassium nitrate (PN), contains (by weight) 1-7 % PN and 0.1-1% of an organic dye (I) containing at least one arylsulphonate (i.e. benzenesulphonate or naphthalenesulphonate) group. Also claimed is a method for suppressing the 32 degrees C transition point of AN, by incorporating 1-7% PN and 0.1-1% (I).
Patent PT-957773-E (PT)
Title: Percutaneous catheter directed intravascular occlusion devices
Inventor: KOTULA FRANK
IPC: A61M25/00
Filed: 1997-04-14
Abstract: The present invention provides a method of forming a medical device and medical devices which can be formed in accordance with the method. In one embodiment, the method includes the steps of a) providing a metal fabric formed of a plurality of strands formed of a metal which can be heat treated to substantially set a desired shape; b) deforming the metal fabric to generally conform to a surface of a molding element; c) heat treating the metal fabric in contact with the surface of the molding element to substantially set the shape of the fabric in its deformed state; and d) removing the metal fabric from contact with the molding element. The resulting metal fabric will define a medical device which can be collapsed for passage through a catheter or the like for deployment in a channel of a patient's body. Medical devices made in accordance with this method can have varying structures.
Patent PT-915937-E (PT)
Inventor: BOHIN FABRICE
IPC: B60R21/235
Filed: 1997-07-03
Abstract: A silicone composition and the uses thereof, particularly as a coating on an airbag for protecting the occupant of a vehicle in the event of a collision, are disclosed. The aim is to provide a silicone composition suitable for coating onto the inner surface of the airbag while significantly reducing the weight of the resulting coating layer to form a protective coating having enhanced high-temperature, mechanical and substrate-adhesion properties. Said aim is achieved in that the composition is free of reinforcing mineral fillers and consists of a mixture of (1) at least one polyorganosiloxane with alkenyl groups bound to the silicon; (2) at least one polyorganosiloxane with hydrogen atoms bound to the silicon; (3) a cross-linking catalyst; (4) an adhesion promoter comprising (4.1) at least one alkoxylated organosilane, (4.2) at least one epoxy-functional organosilicon compound, and (4.3) at least one metal chelate and/or metal alkoxide wherein the metal is selected from the group which consists of Ti, Zr, Ge, Li, Mn, Fe, Al and Mg; (5) at least one polyorganosiloxane resin; and (6) optionally at least one cross-linking inhibitor.
Patent PT-944745-E (PT)
Inventor: BRANDE PIERRE VANDEN
IPC: C23C14/56
Filed: 1997-12-09
Abstract: PCT No. PCT/BE97/00133 Sec. 371 Date Jun. 8, 1999 Sec. 102(e) Date Jun. 8, 1999 PCT Filed Dec. 9, 1997 PCT Pub. No. WO98/26108 PCT Pub. Date Jun. 18, 1998Disclosed is a process for forming a coating on a substrate (2,2') by cathode sputtering, comprising the coating of substrate surfaces (2,2') which have been transferred to a cathode sputtering chamber (1). The substrates vary in width and have a predetermined maximum width. The process involves the use of a target (3) whose surface (4) has an invariable length corresponding approximately to said maximum substrate width. A shift takes place, in accordance with the width of the substrate being coated, between the surface (4) of the target and the substrate surface to be coated, so that the entire surface of the target remains more or less constantly in front of the surface to be coated during the cathode sputtering process.
Patent PT-940372-E (PT)
Inventor: GUIDO BECKER
IPC: C03B32/00
Filed: 1999-02-18
Abstract: The cross section of the entering flow is bounded by wall elements (20) which are positioned, without touching, as near as possible to the outer contour of the glass plate assembly on the support structure. The apparatus has at least one heatable chamber (11) and at least one support structure (2a, 2b) with distancing elements (2c) for glass plates (3), means (13) for producing a flow adjusting the temperature through convection, and a flow channel (12).
Patent SG-72087-G (SG)
Title: Heat-recoverable article
IPC: B29C65/00
Filed: 1987-09-01
Abstract: A heat recoverable article comprises a recoverable fabric and a polymeric layer of at least 0.03mm thickness, and preferably unstressed. Such an article can be recovered by means of an torch to provide an environmental seal around substrates such as cables and pipes.
Patent SG-77891-G (SG)
Title: Cycloaliphatic pharmaceutical compounds
IPC: C07C49/477
Filed: 1991-09-17
Abstract: A compound of the formula    <IMAGE>  (I)  wherein Q is CO, CH(OR), CR(OH), or CR (OC)-lower alkyl); R is H, or C1-2-alkyl; X is hydroxyalkyl, methoxy-C2-11-alkyl, ethoxy-C2-11-alkyl or oxo-C2-11-alkyl, formyl-C2-11-alkyl, carboxy-C2-11-alkyl or (C1-2-alkyl) oxycarbonyl-C2-11-alkyl; c is 1 or 2; p or w are 0, 1 or 2 and the sum of p and w is 1 to 4; and a pharmaceutically acceptable salt thereof.
Patent SG-130292-G (SG)
Title: Diazabicyclo and triazabicyclo primer compositions and use thereof in bonding non-polar substrates
IPC: C08J5/12
Filed: 1992-12-19
Abstract: Use of an adhesion-promoting primer for priming a non-polar substrate such as a polyolefin for bonding with a cyanoacrylate adhesive, characterized in that the primer comprises at least one diazabicyclo or triazabicyclo compound selected from  1,5-diazabicyclo [4.3.0] non-5-ene having the formula:- <CHEM>  1,8-diazabicyclo [5.4.0] undec-7-ene having the formula:- <CHEM>  and 1,5,7-triazabicyclo [4.4.0] dec-5-ene having the formula:- <CHEM>   The primer also contains a solvent.
Patent IE-37117-L (IE)
Title: Recovery of plastics and cellulosic material from waste.
IPC: D01B9/00
Filed: 1973-01-18
Abstract: Process and apparatus for the recovery of both cellulosic fibers and plastic material from plastic-coated papers and boards.
[US4000031A]
Patent IE-900234-L (IE)
Title: Liquid pharmaceutical composition for piperidinoalkanol¹derivatives
IPC: A61K47/26
Filed: 1990-01-22
Abstract: The present invention relates to a liquid pharmaceutical composition comprising (a) a piperidinoalkanol in an amount of from about 2 to about 25 mM; (b) a suitable buffer, selected from the group consisting of gluconic acid buffer, lactic acid buffer, citric acid buffer and acetic acid buffer, in an amount of from about 0.001 to about 0.5 M; and (c) water in an amount of from about 5% to about 99% by weight of the composition.
[EP0380023A1]
Patent IE-31869-L (IE)
Title: Glyceryl esters of acetylsalicylic acid
IPC: C07D317/72
Filed: 1968-04-09
Abstract: 1,226,813. Glyceryl ester derivatives. SCHERICO Ltd. 5 April, 1968 [10 April, 1967], No. 16479/68. Heading C2C. Novel compounds of general Formula I in which R<SP>a</SP> and R<SP>b</SP> are hydrogen atoms or alkyl radicals, the total number of carbon atoms in R<SP>a</SP> and R<SP>b</SP> being not more than 3, and n is 0 or 1 and their pharmaceutically acceptable cyclic acetals and ketals, preferably of Formula II in which R<SP>1</SP> and R<SP>2</SP> are H, alkyl, aryl or aralkyl or together form a polymethylene group are prepared by condensing a compound of formula Y.CH 2 .X<SP>1</SP> by known methods with a compound of formula Z.CO.CR<SP>a</SP>R<SP>b</SP>.A in which X<SP>1</SP> is an α,#-dihydroxy-ethyl or a cyclic acetal or ketal thereof or a vinyl or epoxy ethyl group and either Y and Z represent groups capable of condensing during esterification one of Y and Z providing the grouping III and A is H or Y represents the group IV and Z and A together represent a further C-C bond and where X<SP>1</SP> is a vinyl or epoxyethyl group converting the product by known methods of oxidation or hydrolysis to the ester I. Intermediates isolated are cyanomethyl salicylate (from reaction of chloroacetonitrile with salicylic acid); #,γ - isopropylidenedioxypropyl salicylate (from reaction of cyano derivative with 2,2 - dimethyl - 4 - hydroxymethyl - 1,3- dioxolan); and 0 - (#,γ - isopropylidenedioxypropyl) - N<SP>1</SP>,N - dicyclohexyl - isourea (by reacting dicyclohexylcarbodiimide with 2,2-dimethyl- 4-hydroxymethyl-1,3-dioxolan). Pharmaceutical compositions used in relief of inflammation and pain comprise a compound I in association with a suitable excipient and may be administered enterally, parenterally or topically.
[GB1226813A]
Patent IE-890861-L (IE)
Title: Process for controlling an electrolysis cell
IPC: C25B15/02
Filed: 1989-03-16
Abstract: This cell comprises means for measuring and controlling the entry and exit flow rates, the temperature of the electrolyte, the various concentrations and the current; all these means are connected to a calculating system which determines what are the most probable values of the flow rates, concentrations and current, which is called a coherence treatment, and thus delivers signals to the controlling means. This process is particularly useful for the electrolysis of NaCl in the production of chlorine and sodium hydroxide.
Patent IE-780964-L (IE)
Title: Pressurised fluid generator with outlet pressure controlled¹by varying input flows rate
IPC: F04B17/00
Filed: 1978-05-12
Abstract: A power generator comprising: body means having three chambers separated from each other by fixed fluid-tight partitions and having a central bore. Shaft means are rotatably mounted in the central bore of the body means with at least one end of the shaft means extending from the body means. At least two drive cylinders are mounted in the central one of the chambers in the body means, each of the drive cylinders include two pistons which are slidably mounted in opposition with each piston having two opposite working faces. The piston rods are attached to the corresponding ones of the pistons traversing a respective of the partitions through stationary fluid-tight joints for allowing the piston rods to move therethrough on a pure translational movement. Two swash plate means are provided. Each of the swash plate means includes a respective lateral one of the chambers. Each swash plate means is attached to the shaft means and has means for mechanical attachment of the piston rods from the corresponding pistons in the drive cylinders.
[US4202251A]
Patent FI-853406-L (FI)
Inventor: EKMAN BO MAGNUS
IPC: A61K9/28
Filed: 1985-09-05
Abstract: The present invention concerns a novel pharamceutical preparation having a biphasic release pattern. The preparation comprises a tablet core containing a drug. The tablet is coated with a coating essentially consisting of a film-forming water-insoluble polymer having fine water soluble particles randomly distributed therein. The fine particles include a drug active substance, which is the same as the drug in the core. The drug active substance in the particles may also be different from the one in the tablet core.
Patent IE-33350-L (IE)
Title: Electric cable
IPC: H01B7/02
Filed: 1969-07-21
Abstract: 1,165,528. Water proof cables. STANDARD TELEPHONES & CABLES Ltd. 21 Aug., 1968, No. 39926/68. Heading H1A. To waterproof individual cores 1 of a multicore cable and to prevent axial flow of water when a waterproof sheath is damaged, a laminate 2 comprising a plastics layer 3, preferably polyethylene, and a paper layer 4 is wrapped around each core 1 with the paper 4 innermost and the outer edge sealed at 5, and interstices in the cable are filled with a non-hardening, insulating water-impervious jelly, preferably petroleum jelly. The edge is sealed at 5 by adhesive or the application of heat.
[GB1165528A]
Patent IE-43106-L (IE)
Title: Mocimycin derivatives
IPC: A23K20/195
Filed: 1976-05-13
Abstract: A new antibiotic (now called dihydromocimycin) being a yellow, salt-forming weak acid and its non-toxic, pharmaceutically acceptable salts produced by the microorganism Streptomyces ramocissimus or suitable mutants thereof. The antibiotic has antibacterial properties and has been found to be effective against Treponema dysentery, one of the most common swine diseases. Dihydromocimycin may also be converted into mocimycin, which is an antibiotic which possesses interesting growthpromoting properties when added to animal feed, by a dehydrogenation agent. The dehydrogenation may be carried out with selenium dioxide, preferably in the presence of an organic solvent.
[CA1070630A]
Patent IE-891287-L (IE)
Title: Generating a specific dna probe
IPC: C12Q1/689
Filed: 1989-04-20
Abstract: A method for generating DNA probes specific for an organism and capable of distinguishing in a non-empirical manner between species. The method comprises amplifying, using a pair of oligonucleotide primers, a variable region of the genome of a number of phylogenetically related organisms to, or of a number of organisms suspected of being present in a given sample containing, said organism to be identified and having said variable region in its genome, at least one of said primers corresponding to a DNA sequence known or suspected of being conserved in said organisms, determining the sequence of the amplified region, selecting said sequence or a portion thereof to generate said probe specific for said organism to be identified by comparison with said other amplified regions and defining the hybridization conditions required to obtain a specific signal based on the precise nucleotide sequence of the selected probe. Specific probes are disclosed for a variety of species including Aeromonas hydrophila, Aeromonas salmonicida, Clostridium difficile, Mycobacterium bovis, Mycobacterium tuberculosis and Salmonella typhimurium.
Patent IE-781756-L (IE)
Title: 2-hydrazonopropionic acid derivatives.
IPC: A61K31/22
Filed: 1978-08-31
Abstract: A 2-hydrazonopropionic acid derivative of the formula <IMAGE> wherein R is an aliphatic hydrocarbon radical, and X is a valency bond or a divalent aliphatic hydrocarbon radical containing up to 4 carbon atoms, with the proviso that when X is a valency bond, R cannot be saturated cycloalkyl, or a physiologically compatible salt, lower alkyl ester or amide thereof, which exhibit hypoglycaemic activity.
[US4206231A]
Patent IE-40173-L (IE)
Title: 3, 4 - dihydro - 1, 2, 4 - triazines; herbicides
IPC: A61P33/10
Filed: 1974-09-17
Abstract: New 4-acylaminophenylacetamidines of the formula:
[US3970699A]
Patent IE-842215-L (IE)
Title: Aerosol container
IPC: B65D83/14
Filed: 1984-08-30
Abstract: A valve cup (60) for an aerosol dispensing can has a side wall (68) of lesser girth at the bottom than in an upper zone of which a portion is adapted to intensify the seal in the swaged seam between the cup curl (70') and the body curl (22). The side wall has for example a step (88) which acts as a fulcrum. In the swaged seam the seal is intensified in the area adjacent the step and down to a second point of contact where the side wall is deformed by the swaging tool (38) into contact with the body wall (1).
[WO8501032A1]